ISSN 2500-2236
DOI-prefix: 10.18527/2500-2236

Search


Volume 5, Number 1, 2018
... This work was supported by the RSF-FWF grant No 18-45-05002 (A VLP approach to combat post influenza bacterial infections). ...
Authors: Andrej Egorov
Volume 4, Number 1, 2017
... In the experiments dealing with secondary bacterial pneumonia following influenza, the animals were infected i.n. with 0.5 MLD50/0.1 ml of mouse-adapted A/CA/04/09 virus. S. ...
Authors: Irina A. Leneva, Irina N. Falynskova, Nailya R. Makhmudova, Ekaterina A. Glubokova, Nadezhda P. Kartashova, Eugenia I. Leonova, Natalya A. Mikhailova, Irina V. Shestakova
Том 4, номер 1, 2017
... At doses of 50 and 100 mg/kg/day, triazavirine was highly effective in the treatment of the secondary bacterial pneumonia following influenza infection in mice. ...
Authors: И. А. Ленева, И. Н. Фалинскова, Н. Р. Махмудова, Е. А. Глубокова, Н. П. Карташова, Е. И. Леонова, Н. А. Михайлова, И. В. Шестакова
Том 5, номер 1, 2018
... This virus is capable to cause catastrophic pandemics with high mortality mainly due to the secondary bacterial pneumonia. ...
Authors: А. Ю. Егоров
Volume 4, Number 1, 2017
... The first part of this review is focused on an analysis of the mechanisms of action of antibiotics that are used in clinical practice as well as the mechanisms of bacterial resistance. ...
Authors: Alexander Zhivich
Volume 7, Number 1, 2020
... Some colonies were reseeded into Petri dishes with the CRL and CRL.2 media using a bacteriological loop in order to obtain a pure bacterial culture. ...
Authors: Olga Y. Slovareva
Volume 6, Number 1, 2019
... Since bacteria acquire resistance to antibiotics very quickly and the development of new antibiotics is a lengthy process, the search for new approaches to stop the spread of bacterial resistance is extremely ...
Authors: Alexander Zhivich
Volume 2, Number 1, 2015
... It was only in one pneumonia case that the causative agent was proved to be metapneumovirus. ...
Authors: Anna A. Sominina, Maria M. Pisareva, Mikhail P. Grudinin, Mikhail Yu. Eropkin, Nadezhda I. Konovalova, Vera F. Sukhovetskaya, Olga I. Afanasieva, Lubov V. Voloshuk, Andrey B. Komissarov, Zhanna V. Buzitskaya, Artem V. Fadeev, Kirill A. Stolyarov, Elizaveta A. Smorodintseva, Veronika S. Afanasieva, Marina A. Yanina, Vitalii V. Gonchar, Ludmila V. Osidak, Alexey A. Go
Volume 6, Number 1, 2019
... The antimicrobial activity of the corresponding compound was determined by measuring the diameters of the inhibition zones of bacterial growth. ...
Authors: Nikita G. Sidorov, Alexey D. Kravchenko, Alexander V. Poddubikov, Vera G. Arzumanian 
Том 7, номер 1, 2020
... Reliable information on the distribution of these bacterial strains in the Russian Federation is limited. ...
Authors: О. Ю. Словарева
Volume 6, Number 1, 2019
... Production of recombinant NSP protein in bacterial cells For the synthesis of NSP protein in the E. ...
Authors: Oleg P. Zhirnov, Tatyana E. Konakova, Darisuren Anhlan, Stephan Ludwig, Elena I. Isaeva
Volume 6, Number 1, 2019
... Bacterial pellets were obtained from cultures by centrifugation at 5000 g (Eppendorf, 5804R) for 15 min. ...
Authors: Nikita D. Yolshin, Aram A. Shaldzhyan, Sergey A. Klotchenko
Том 4, номер 1, 2017
... The first part of this review is focused on an analysis of the mechanismsof action of antibiotics that are used in clinical practice as well as the mechanisms of bacterial resistance. ...
Authors: Александр Живич
Volume 2, Number 1, 2015
... The role of complement system factors in bacterial and viral infections is very well known. ...
Authors: O. I. Kiselev, A. B. Komissarov, O.S.Konshina, M.N.Dmitrieva, E.G.Deyeva, T.V.Sologub, V.I.Pokrovskiy
Том 6, номер 1, 2019
... concentration of the tested compound and bacterial strain. ...
Authors: Н. Г. Сидоров, А. Д. Кравченко, А. В. Поддубиков, В. Г. Арзуманян
Volume 3, Number 1, 2016
... Thus, the patients infected with the influenza B virus strains that bind not only to the SAa2-6Gal-chains but also SAa2-3Gal ones (avian type) are prone to developing pneumonia and more ...
Authors: Evgeniy V. Sorokin, Tatyana R. Tsareva, Anna A. Sominina, Maria M. Pisareva, Andrey B. Komissarov, Аnna А. Kosheleva
Том 6, номер 1, 2019
... Since bacteria acquire resistance to antibiotics very quickly and the development of new antibiotics is a lengthy process, the search for new approaches to stop the spread of bacterial resistance is extremely ...
Authors: Александр Живич
Volume 7, Number 1, 2020
... However, almost 55% of symptomatic patients develop respiratory failure approximately by the eighth day of the disease, associated with bilateral multi-lobal pneumonia [ ...
Authors: Andrej Egorov, Julia Romanova
Volume 1, number 1, 2014
... witnessed the sudden appearance and rapid spread through China, Europe, and the US of a new infectious disease called severe acute respiratory syndrome (SARS), which is also known as “atypical pneumonia ...
Authors: Dr. J. Romanova
Volume 3, Number 1, 2016
... characterized by the development of the catarrhal inflammation of the respiratory tract, general depression, short-term fever, and dry sickly cough and in the severe cases – by the development of pneumonia ...
Authors: Kaissar Tabynov